Merck portfolio
Merck has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Aktis Oncology's $84M Series A round in August 2022, alongside Vida Ventures, TCG Crossover, Pappas Capital and 6 others. That company is in Health and bio.
What Merck invests in
- Health and bio · 1 · 100%
How Merck invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $84M |
Share is of the 1 round on Recent Funding that name Merck. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Merck portfolio companies
AAktis Oncology$84MSeries A · Aug 2022
| Company | Round with Merck | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $84M | $336M | Sep 1, 2024 Series B+ |
Most frequent co-investors
MMRL Ventures Fund1 shared round · last Aug 26, 2022
TTCG Crossover1 shared round · last Aug 26, 2022
PPappas Capital1 shared round · last Aug 26, 2022
MMPM Capital1 shared round · last Aug 26, 2022
VVida Ventures1 shared round · last Aug 26, 2022
- NNS Investment1 shared round · last Aug 26, 2022
- OOctagon Capital Advisors1 shared round · last Aug 26, 2022
NNovartis1 shared round · last Aug 26, 2022
MMirae Asset Venture Investment1 shared round · last Aug 26, 2022
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
AAngel Academe1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moDDeepWork Capital1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Merck, which is a subset of its real portfolio. API: /api/v1/investors/merck (get a free API key). More: the most active VC firms and new venture capital funds.